Document Detail


Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy.
MedLine Citation:
PMID:  22182955     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Ischemic cardiogenic shock is a complex, self-perpetuating pathological process that frequently causes death irrespective of medical therapy. Early definition of coronary anatomy is a pivotal step towards survival. Those destined to develop shock are likely to have three-vessel or left main stem disease with previously impaired left ventricular function. Early reperfusion of the occluded artery can limit infarct size, but ischemia-reperfusion injury or the 'no-reflow' phenomenon can preclude improvement in myocardial contractility. Emergence of shock depends upon the volume of ischemic myocardium, stroke volume, and peripheral vascular resistance. If cytokine release triggers the systemic inflammatory response, systemic vascular resistance falls and inadequate coronary perfusion pressure heralds the downward spiral. Survival depends on early recognition of shock, followed by aggressive targeted treatment of left, right, or biventricular failure. The goal is to prevent end-organ dysfunction and severe metabolic derangement by raising mean arterial pressure, which is achieved with inotropes and vasopressors, often at the expense of tachycardia, elevated myocardial oxygen consumption, and extended ischemia. The value of intra-aortic balloon counter-pulsation is now questioned in patients with advanced shock. When mean arterial pressure is <55 mmHg with serum lactate >11 mmol/l, death is likely and mechanical circulatory support becomes the only chance for survival.
Authors:
Stephen Westaby; Rajesh Kharbanda; Adrian P Banning
Related Documents :
11758075 - Lipid lowering and coronary heart disease risk: how appropriate are the national guidel...
20712525 - Pharmacogenetic interactions between abcb1 and slco1b1 tagging snps and the effectivene...
11837985 - Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of gis...
10695705 - Strategies for implementing lipid-lowering therapy: pharmacy-based approach.
17940855 - Cardiac electrophysiological characteristics of the mdx ( 5cv ) mouse model of duchenne...
16633095 - Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myoca...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-20
Journal Detail:
Title:  Nature reviews. Cardiology     Volume:  -     ISSN:  1759-5010     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101500075     Medline TA:  Nat Rev Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Departments of Cardiothoracic Surgery, Headley Way, Headington, Oxford OX3 9DU, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Therapeutic effects of cranial osteopathic manipulative medicine: a systematic review.
Next Document:  Gold nanoparticle-enabled biological and chemical detection and analysis.